🇺🇸 FDA
Patent

US 9303000

Olefin containing nuclear transport modulators and uses thereof

granted A61PA61P17/00A61P17/06

Quick answer

US patent 9303000 (Olefin containing nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P17/00, A61P17/06, A61P19/02, A61P29/00